Does Plant Sterols LDL Cholesterol Meta-Analysis work?

Updated July 2026

Quick Answer

Plant Sterols LDL Cholesterol Meta-Analysis has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: So, maintaining low levels of LDL-c over time, following the emerging scientific consensus of ‘lower is better, and earlier is better’, could lead to a substantial reduction in ASCVD risk [].

Key Takeaways

  • 01So, maintaining low levels of LDL-c over time, following the emerging scientific consensus of ‘lower is better, and earlier is better’, could lead to a substantial reduction in ASCVD risk []. [Ferrandino Martina (2026)]
  • 02The aim of this narrative review is to provide an updated overview of the complex genetic architecture underlying hypercholesterolemia and increased cardiovascular risk by discussing the contribution of monogenic disorders, polygenic risk scores (PRS) and lipoprotein(a)—Lp(a)—to increased LDL-c levels (). [Ferrandino Martina (2026)]
  • 03This could lead to improved cardiovascular prevention with a more comprehensive and individualized approach and, consequently, better patient management. [Ferrandino Martina (2026)]
  • 041 2 Figure 1 Atherosclerotic cardiovascular disease (ASCVD) is the main cause of mortality worldwide, with low-density lipoprotein cholesterol (LDL-c) as the main driver of its pathogenesis []. [Ferrandino Martina (2026)]
The current Migaku evidence database contains 2 reusable source documents for Plant Sterols LDL Cholesterol Meta-Analysis. This answer focuses on strength of evidence and what the studies can or cannot prove. - So, maintaining low levels of LDL-c over time, following the emerging scientific consensus of ‘lower is better, and earlier is better’, could lead to a substantial reduction in ASCVD risk []. [Ferrandino Martina (2026); evidence level 3] - The aim of this narrative review is to provide an updated overview of the complex genetic architecture underlying hypercholesterolemia and increased cardiovascular risk by discussing the contribution of monogenic disorders, polygenic risk scores (PRS) and lipoprotein(a)—Lp(a)—to increased LDL-c levels (). [Ferrandino Martina (2026); evidence level 3] - This could lead to improved cardiovascular prevention with a more comprehensive and individualized approach and, consequently, better patient management. [Ferrandino Martina (2026); evidence level 3] - 1 2 Figure 1 Atherosclerotic cardiovascular disease (ASCVD) is the main cause of mortality worldwide, with low-density lipoprotein cholesterol (LDL-c) as the main driver of its pathogenesis []. [Ferrandino Martina (2026); evidence level 3] - ( ) 1 1 2 3 4 5 6 7 9 10 12 10 12 13 10 14 10 12 15 16 17 11 10 Plant sterols (PS) (including phytosterols and phytostanols) are C28 and C29-steroidal carbonic alcohols similar to cholesterolFig., being β-sitosterol, campesterol and stigmasterol those found in plants in greatest proportion. [Musto Leonardo (2026); evidence level 3] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Sources

  1. Genetic Influence on LDL-Cholesterol Levels: Role of Polygenic Risk Scores and Lp(a) Beyond Monogenic Hypercholesterolemia
  2. Overview of the effect of dietary supplementation with plant sterols on low-grade inflammation, endothelial dysfunction and oxidative stress in patients with hypercholesterolemia